Citadel Advisors »

Atea Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 625k 3.35
2024-06-30 $2.2M 667k 3.31
2024-03-31 $1.4M 342k 4.04
2023-12-31 $579k 190k 3.05
2023-09-30 $1.8M 603k 3.00
2023-06-30 $5.6M 1.5M 3.74
2023-03-31 $5.4M 1.6M 3.35
2022-12-31 $3.3M 689k 4.81
2022-06-30 $3.5M 494k 7.10
2022-03-31 $13M 1.9M 7.22
2021-12-31 $20M 2.2M 8.94
2021-09-30 $12M 333k 35.06
2021-06-30 $4.5M 211k 21.47
2021-03-31 $1.2M 20k 61.67
2020-12-31 $7.0M 168k 41.78